ApoB and LDL particle number are the primary determinants of atherogenic particle burden and cardiovascular risk.

The understanding of cardiovascular risk has evolved from measuring cholesterol mass (LDL-C) to quantifying the actual number of atherogenic particles. Evidence confirms that Apolipoprotein B (ApoB) and LDL particle number (LDL-P) are the primary determinants of the initiation and progression of atherosclerosis.

Clinical and effectiveness evidence

Large-scale epidemiological studies and Mendelian randomization data consistently show that ApoB and LDL-P are superior predictors of cardiovascular events compared to traditional lipid markers.

• ApoB as a direct proxy: Because every atherogenic lipoprotein—including LDL, VLDL, and IDL—carries exactly one ApoB molecule, measuring ApoB provides a precise count of the total number of particles capable of entering the arterial wall.
• Predictive superiority: Research involving over 400,000 participants (e.g., UK Biobank) indicates that when LDL-C and ApoB levels are discordant, the risk of myocardial infarction tracks with ApoB. High particle counts represent a high risk even if the cholesterol concentration within those particles is low.

Mechanistic explanations

The "response-to-retention" hypothesis explains why particle number is the critical metric for plaque formation:

• Arterial Entrapment: Atherosclerosis begins when ApoB-containing particles cross the endothelium and become trapped in the subendothelial space. This occurs through a concentration-dependent binding process between the positively charged residues on the ApoB protein and negatively charged proteoglycans in the arterial wall.
• Inflammatory Cascade: Once trapped, these particles undergo oxidative and enzymatic modifications. These modified lipoproteins act as damage-associated molecular patterns (DAMPs), activating the NLRP3 inflammasome.
• Plaque Biology: This activation recruits monocytes that differentiate into macrophages. These cells ingest the modified lipids to become foam cells, secreting pro-inflammatory cytokines like interleukin-1β (IL-1β). Metrics like Lp-PLA2 activity further reflect this inflammatory state, where the hydrolysis of oxidized phospholipids leads to necrotic core expansion and plaque instability.

Bottom line

ApoB and LDL-P reflect the absolute burden of atherogenic particles; a higher concentration of these particles increases the probability of arterial retention and the subsequent inflammatory response that drives cardiovascular disease.